Ep175: Andy Scharenberg on in vivo CAR-T cell therapies
The Long Run with Luke Timmerman - Podcast autorstwa Timmerman Report
Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.
The Long Run with Luke Timmerman - Podcast autorstwa Timmerman Report
Andy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.